Overview
Nebulabio is a specialized antibody discovery and engineering team focused on generating mouse-derived monoclonal antibodies for research, assay development, therapeutic discovery, and translational programs. By integrating controlled immunization strategies, antigen-specific B cell isolation, hybridoma and single-cell V(D)J sequencing workflows, and recombinant expression platforms, we deliver fully characterized mouse monoclonal antibodies with native heavy–light chain pairing and traceable clonal documentation. Our service supports applications ranging from basic target biology to therapeutic antibody lead generation with structured analytical validation.
☞Nebulabio Mouse Antibody Platform
Mouse immunization remains one of the most established and versatile routes for monoclonal antibody discovery. Our platform provides access to antigen-specific murine B cell repertoires through classical hybridoma fusion, single B cell sorting with paired-chain recovery, or recombinant antibody reformatting pipelines. Candidate sequences are cloned into mouse IgG subclass backbones or reformatted into recombinant IgG, Fab, or scFv formats as required, enabling controlled production, consistent QC, and downstream format flexibility.
☞Supported Options
Sample Types • Splenocytes from immunized mice • Lymph node cell suspensions • PBMCs from immunized animals (project-dependent) • Hybridoma supernatants or established hybridoma clones • Cryopreserved murine immune cells | Immunization and Donor Strategies • Active immunization with recombinant proteins, peptides, DNA, or cells • Conformational antigen strategies using mammalian- expressed proteins • Adjuvant optimization and boost schedule configuration • Tolerance-breaking approaches for conserved mammalian targets (project-dependent) • Rapid immunization schedules for time-sensitive projects | |
Antigen Probes and Screening Formats • Recombinant proteins prepared in appropriate expression systems • Cell-surface staining using antigen -expressing cell lines • Peptide or domain-specific probes • Biotinylated antigens with fluorescent streptavidin labeling • Competitive binding and epitope binning configurations | Discovery Routes • Hybridoma generation (PEG-mediated fusion with myeloma partners) • Antigen-specific single B cell sorting and paired-chain sequencing • Hybridoma sequencing and recombinant rescue • Phage or display library construction from murine repertoires (project-dependent) | |
Mouse IgG Subclass and Format Support • Mouse IgG1, IgG2a, IgG2b, IgG3 subclasses • Recombinant IgG reformatting for controlled expression • Fab and scFv fragment generation • Sequence-defined conversion to chimeric or humanized formats (project-configured) | ||
☞Principle of Mouse-derived Antibody Production
Mouse-derived monoclonal antibody generation captures antigen-driven adaptive immune responses following controlled immunization. Antigen-specific B cells are isolated either through hybridoma fusion or probe-based single-cell sorting, preserving native heavy–light chain pairing that determines specificity and affinity. Paired variable regions are sequenced and cloned into defined murine constant-region frameworks for recombinant production in mammalian systems, ensuring consistent assembly and glycosylation. Sequence-level documentation enables reproducibility, reformatting, and rational selection of candidates based on binding kinetics, epitope specificity, and project-defined functional criteria.
| ☎ +86-15801534258 | ✉ info@nebulabio.cn | Request a Quote ☜ |
☞Nebulabio’s Service Process
Project Design and Immunization Strategy We define the antigen format, immunization schedule, and screening route aligned with the intended downstream application. Key Steps
|
Immunization and Immune Monitoring We execute immunization programs and monitor immune response kinetics to optimize harvest timing. Key Steps
|
Hybridoma Generation or Single B Cell Isolation We generate monoclonal candidates through fusion-based or single-cell routes. Key Steps
|
Screening, Sequencing, and Candidate Selection We identify high-performing clones based on binding and project-defined functional metrics. Key Steps
|
Recombinant Expression and Purification We express selected antibodies in mammalian systems for standardized characterization. Key Steps
|
Delivery and Documentation We provide purified antibodies with complete sequence and analytical documentation. Deliverables
|
☞Featured Applications
■ Target Biology and Mechanism-of-Action Studies
Mouse-derived monoclonal antibodies are widely used as standardized reagents for receptor mapping, ligand blocking, pathway modulation, and functional validation. Sequence-defined clones support reproducibility across mechanistic studies and longitudinal research programs.
■ Therapeutic Antibody Lead Generation
Murine antibodies serve as starting points for chimerization or humanization workflows in early therapeutic discovery. Controlled immunization and clone selection strategies improve the probability of identifying high-affinity binders suitable for downstream engineering.
■ Neutralization and Infectious Disease Research
Mouse monoclonals are frequently used in viral neutralization assays, pathogen binding studies, and in vivo validation models. Documented clone identity supports consistency across assay development cycles.
■ Diagnostic and Immunoassay Reagent Development
Mouse antibodies remain foundational reagents in ELISA, Western blot, flow cytometry, and immunohistochemistry. Recombinant expression and sequence traceability reduce lot-to-lot variability in assay development workflows.
| For more information, please contact us at info@nebulabio.cn or +86-15801534258. |
